Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Beule, Dieter Dr. (2) Cakmak-Görür, Nese Dr. (1) Daniel, Peter Prof. Dr. (2) Dhamodaran, Arunraj (1) Kammertöns, Thomas Dr. (6) Kieback, Elisa Dr. (1) Kopp, Joachim Dr. (2) Marko, Lajos Dr. (1) Pezzutto, Antonio Prof. Dr. (5) Poncette, Lucia (1) Schlag, Peter M. Prof. Dr. (1) Siffrin, Volker (1) Stein, Ulrike Prof. Dr. (1) Uckert, Wolfgang Prof. Dr. (5) Walther, Wolfgang Prof. Dr. (1) Willimsky, Gerald Dr. (6) (-) Blankenstein, Thomas Prof. Dr. (28) (-) Leisegang, Matthias Prof. Dr. rer. nat. (3) (-) Lorenz, Felix Dr. (1) (-) Rhein, Simone Dr. (1) Bioinformatics and Omics Data Science (1) Biologie maligner Lymphome (15) Entwicklungsneurobiologie (1) Genetik und Genomik von Herz- Kreislauferkrankungen (1) (-) Molekulare Immunologie und Gentherapie (28) Proteom Dynamik (1) Strukturbiologie Membran-assoziierter Prozesse (1) Systembiologie von Gen-regulatorischen Elementen (1) Translational Bioinformatics (2) Translationale Onkologie solider Tumore (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) (-) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) 2006 (1) 2007 (5) (-) 2008 (5) 2009 (2) 2010 (7) (-) 2011 (5) 2012 (6) 2013 (11) 2014 (3) (-) 2015 (3) 2016 (4) 2017 (6) 2018 (4) (-) 2019 (6) 2020 (1) 2021 (4) 2022 (6) 2023 (4) 2024 (2) 28 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Leisegang, Matthias Prof. Dr. rer. nat.Lorenz, Felix Dr.Rhein, Simone Dr.Molekulare Immunologie und Gentherapie 19982008201120152019 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Januar 1998 / Hum Gene Ther RNA levels of human retrovirus receptors Pit1 and Pit2 do not correlate with infectibility by three retroviral vector pseudotypes W. Uckert G. Willimsky F.S. Pedersen T. Blankenstein L. Pedersen 15. Januar 2008 / Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert 07. Juli 2008 / J Exp Med Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness G. Willimsky M. Czeh C. Loddenkemper J. Gellermann K. Schmidt P. Wust H. Stein T. Blankenstein 01. Oktober 2008 / Int J Cancer SV40 large T antigen-transformed human primary normal and cancerous mammary epithelial cells are phenotypically similar but can be distinguished in 3D culture with selection medium L.P. Li G. Willimsky S. Seitz Y. Xu Y. Li L.E. Schwarz P.M. Schlag T. Blankenstein 11. November 2008 / Proc Natl Acad Sci U S A Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas A. Kruschinski A. Moosmann I. Poschke H. Norell M. Chmielewski B. Seliger R. Kiessling T. Blankenstein H. Abken J. Charo 08. September 2008 / Canc Lett Ablation of TNF or lymphotoxin signaling and the frequency of spontaneous tumors in p53-deficient mice D.V. Kuprash Z. Qin D. Ito S.I. Grivennikov K. Abe L.N. Drutskaya T. Blankenstein S.A. Nedospasov 15. Januar 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens 01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto 01. Januar 1998 / Adv Exp Med Biol Retroviral B7.1 gene transfer in cancer cells protects cytotoxic T cells from deletion by "veto" apoptosis P.T. Daniel A. Kroidl S. Cayeux C. Scholz I. Sturm T. Blankenstein A. Pezzutto B. Doerken 01. Januar 1998 / Hum Gene Ther Strong immunogenic potential of a B7 retroviral expression vector: Generation of HLA-B7-restricted CTL response against selectable marker genes D. Jung E. Jaeger S. Cayeux T. Blankenstein C. Hilmes J. Karbach U. Moebius A. Knuth C. Huber B. Seliger Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Nächste Seite Next › Letzte Seite Last »
01. Januar 1998 / Hum Gene Ther RNA levels of human retrovirus receptors Pit1 and Pit2 do not correlate with infectibility by three retroviral vector pseudotypes W. Uckert G. Willimsky F.S. Pedersen T. Blankenstein L. Pedersen
15. Januar 2008 / Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert
07. Juli 2008 / J Exp Med Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness G. Willimsky M. Czeh C. Loddenkemper J. Gellermann K. Schmidt P. Wust H. Stein T. Blankenstein
01. Oktober 2008 / Int J Cancer SV40 large T antigen-transformed human primary normal and cancerous mammary epithelial cells are phenotypically similar but can be distinguished in 3D culture with selection medium L.P. Li G. Willimsky S. Seitz Y. Xu Y. Li L.E. Schwarz P.M. Schlag T. Blankenstein
11. November 2008 / Proc Natl Acad Sci U S A Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas A. Kruschinski A. Moosmann I. Poschke H. Norell M. Chmielewski B. Seliger R. Kiessling T. Blankenstein H. Abken J. Charo
08. September 2008 / Canc Lett Ablation of TNF or lymphotoxin signaling and the frequency of spontaneous tumors in p53-deficient mice D.V. Kuprash Z. Qin D. Ito S.I. Grivennikov K. Abe L.N. Drutskaya T. Blankenstein S.A. Nedospasov
15. Januar 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto
01. Januar 1998 / Adv Exp Med Biol Retroviral B7.1 gene transfer in cancer cells protects cytotoxic T cells from deletion by "veto" apoptosis P.T. Daniel A. Kroidl S. Cayeux C. Scholz I. Sturm T. Blankenstein A. Pezzutto B. Doerken
01. Januar 1998 / Hum Gene Ther Strong immunogenic potential of a B7 retroviral expression vector: Generation of HLA-B7-restricted CTL response against selectable marker genes D. Jung E. Jaeger S. Cayeux T. Blankenstein C. Hilmes J. Karbach U. Moebius A. Knuth C. Huber B. Seliger